This graft versus leukemia (GvL) effect is associated with a mismatch between host HLA groups and donor NK cell KIR ligands, in which the lack of “self” MHC class-I molecules on leukemia cells is crucial to unrestraint NK cell cytotoxicity (104–106). Here, KIR3DL1 is linked to leukemia.